Company Profiles

driven by the PitchBook Platform

Advent Pharmaceuticals

Description

Operator of a drug development company. The company focuses on developing inhaled drug products for the treatment of asthma and other pulmonary diseases.

2001

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

3

Investors

Description

Operator of a drug development company. The company focuses on developing inhaled drug products for the treatment of asthma and other pulmonary diseases.

Website:

www.advent-pharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Drug Delivery
Pharmaceuticals

Primary Office

23 Normanby Road Notting Hill, Victoria 3168Australia +61 (0)3 9544 8785
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Advent Pharmaceuticals's full profile, request a free trial.

Advent Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Advent Pharmaceuticals Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
CM CapitalVenture CapitalMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
QIC BioVenturesVenture CapitalMinority000 0000000 0000
CM Capital Venture Capital
Individual Investor Angel (individual)
QIC BioVentures Venture Capital

Advent Pharmaceuticals Executive Team (1)

NameTitleBoard
Seat
Contact
Info
Kenneth WindleChief Executive Officer, Chairman & Managing Director
Kenneth Windle Chief Executive Officer, Chairman & Managing Director
Request full access to PitchBook